[Role of genetic factors in pneumonia and COVID-19].

Bedeutung der Genetik für die Pneumonie und COVID-19.
Immune defect Mortality Polygenetic risk SARS-CoV‑2 Susceptibility

Journal

Der Pneumologe
ISSN: 1613-5636
Titre abrégé: Pneumologe (Berl)
Pays: Germany
ID NLM: 101233663

Informations de publication

Date de publication:
2021
Historique:
accepted: 03 02 2021
pubmed: 16 3 2021
medline: 16 3 2021
entrez: 15 3 2021
Statut: ppublish

Résumé

Pneumonia causes the highest mortality of all infectious diseases worldwide. The most common pathogens are bacteria but there are also epidemic or pandemic lung infections caused by influenza or coronaviruses, such as the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition to the occurrence of antibiotic resistance and immune pathologies, such as in sepsis, important challenges lie in considering the susceptibility of individual patients. Here, age, medication and comorbidities are considered; however, there is also clear evidence of genetic influences on the individual risk of developing pneumonia or developing a severe course of the disease. This article discusses the genetic influences on pneumonia and the clinical significance.

Identifiants

pubmed: 33716601
doi: 10.1007/s10405-021-00385-2
pii: 385
pmc: PMC7934978
doi:

Types de publication

English Abstract Journal Article Review

Langues

ger

Pagination

212-217

Informations de copyright

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021.

Auteurs

Wilhelm Bertrams (W)

Institut für Lungenforschung, Universities of Gießen and Marburg Lung Center (UGMLC), Philipps-Universität Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Deutschland.

Anna Lena Jung (AL)

Institut für Lungenforschung, Universities of Gießen and Marburg Lung Center (UGMLC), Philipps-Universität Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Deutschland.

Michael Maxheim (M)

Klinik für Innere Medizin mit Schwerpunkt Pneumologie, Universitätsklinikum Marburg, Philipps-Universität Marburg, Marburg, Deutschland.

Bernd Schmeck (B)

Institut für Lungenforschung, Universities of Gießen and Marburg Lung Center (UGMLC), Philipps-Universität Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Deutschland.
Klinik für Innere Medizin mit Schwerpunkt Pneumologie, Universitätsklinikum Marburg, Philipps-Universität Marburg, Marburg, Deutschland.

Classifications MeSH